Neck Squamous Cell Carcinoma

Semaphorin 4D produced by human head and neck squamous cell carcinoma induces myeloid derived suppressor cells expansion from peripheral blood monocytes
Rania H Younis, Kyu Lee Han, Tonya Webb

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P280; DOI: 10.1186/2051-1426-3-S2-P280
MDSCs enhance tumor cell proliferation in a caspase-1 related inflammasome cytokines dependent way
Qi Zeng, Jesse Qualliotine, Richard Blosser, Drew Pardoll, Young Kim

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P317; DOI: 10.1186/2051-1426-3-S2-P317
Level of PD-1 expression on CD8+ T cells influence prognosis and respond to PD-1 therapy in a murine model
Benjamin A Kansy, Raghvendra M Srivastava, Hyun-Bae Jie, Gulidanna Shayan, Yu Lei, Jing Li, William Gooding, Sven Brandau, Stephan Lang, Nicole Schmitt, Gordon J Freeman, David A Clump, Robert L Ferris

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P228; DOI: 10.1186/2051-1426-3-S2-P228
An HPV-E6/E7 immunotherapy plus PD-1 checkpoint inhibition results in tumor regression and reduction in PD-L1 expression
Adrian E Rice, Yvette Latchman, Joseph P Balint, John H Lee, Elizabeth S Gabitzsch, Frank R Jones

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P449; DOI: 10.1186/2051-1426-3-S2-P449
Mcl-1 expression influcences CD8+ anti-tumor immunity.
Lukas W Pfannenstiel, Brian R Gastman

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P323; DOI: 10.1186/2051-1426-3-S2-P323
Evaluation of the immunogenicity of aldhhigh human head and neck squamous cell carcinoma cancer stem cells in vitro
Qiao Li, Mark Prince

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P28; DOI: 10.1186/2051-1426-3-S2-P28
An evaluation of autologous tumor-reactive TIL generation from head and neck squamous cell cancers
Tarsem Mougdil, Christopher Paustian, Zipei Feng, Rom Leidner, Christopher Dubay, Brendan D Curti, Hong-Ming Hu, Walter Urba, Carlo Bifulco, Bernard Fox, Brian Bell

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P37; DOI: 10.1186/2051-1426-3-S2-P37
Utilizing quantitative immunohistochemistry for relationship analysis of tumor microenvironment of head and neck cancer patients
Zipei Feng, Tarsem Moudgil, Allen Cheng, Christopher Paustian, Rieneke van de Ven, Christopher Dubay, Hong-Ming Hu, Tuan Bui, Tyler Hulett, Traci Hilton, Carlo Bifulco, Richard B Bell, Bernard A Fox

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P258; DOI: 10.1186/2051-1426-2-S3-P258
PD-L1 is preferentially expressed on CD44+ tumor-initiating cells in head and neck squamous cell carcinoma
Yunqin Lee, John Sunwoo

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P270; DOI: 10.1186/2051-1426-2-S3-P270
OX40 and other immunoregulatory molecules are highly expressed on tumor infiltrating lymphocytes in oral, head and neck squamous cell carcinoma
Ryan Montler, Richard B Bell, Rom Leidner, Marka Crittenden, Tuan Bui, Allen Cheng, Ashish Patel, Christopher Tucker, Colin Thalhofer, Andrew Weinberg

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P113; DOI: 10.1186/2051-1426-2-S3-P113

Log in using your username and password

Main menu

Log in using your username and password

You are here

Neck Squamous Cell Carcinoma